FAQs

Applications from all sources with secure intellectual property rights will be considered, including domestic or foreign, public or private, nonprofit or for-profit. Details regarding specific requirements can be found in the NIH Grants Policy Statement Part II: Terms and Conditions of NIH Grant Awards. If the proposed work is to be done outside of the US or by a foreign company, please provide a strong justification as to why the work cannot be done in the US or by a domestic company, and realize that applications outside of the US may require additional regulatory review and oversight.

Management of intellectual property will be determined by the proposal applicant’s institutional policies.

Protecting proprietary information is the responsibility of the applicant and the applicant institution. Consistent with NIH policy, applicants are discouraged from submitting information considered proprietary unless it is deemed essential for proper evaluation of the application. However, when the application contains information that constitutes trade secrets, or information that is commercial or financial, or information that is confidential or privileged, do identify the pages in the application that contain this information by marking those paragraphs or lines with an asterisk (*) at the beginning of the paragraph. Indicate at the beginning of the Research Plan which pages contain asterisks and include a note stating: "The following sections marked with an asterisk contain proprietary/privileged information that [name of applicant] requests are not released to persons outside the Government, except for purposes of review and evaluation." When information in the application constitutes trade secrets or information that is commercial or financial, or information that is confidential or privileged, it is furnished to the Government in confidence with the understanding that the information shall be used or disclosed only for evaluation of this application. If a grant is awarded as a result of or in connection with the submission of this application, the Government shall have the right to use or disclose the information to the extent authorized by law.

If the proposed work is to be done outside of the US or by a foreign company, please provide a strong justification as to why the work cannot be done in the US or by a domestic company, and realize that applications outside of the US may require additional regulatory review and oversight.

CAPCaT awards $100,000 grants that cover direct costs for a twelve-month period. Additionally, indirect costs are covered at a performance site’s federally negotiated rate and/or at the standard rate of 10% for companies (unless a company can substantiate a different federally negotiated rate). Only single-period applications are accepted.

CAPCaT plans to fund up to four awards for the 2025-26 cycle, pending the receipt of meritorious applications. At least one project that incorporates complementary and integrative health approaches may be funded.

All applications must be submitted through the online submission site.

Follow the instructions on the online submission site. The application does not need to be completed all at once. Applicants may log on as many times as they wish (work will be saved in the system) until the deadline. 

Proposals are peer-reviewed confidentially. The review panels are made up of individuals with appropriate expertise in medical innovation from clinical, engineering, regulatory, technical, scientific, and/or business perspectives. Full proposal applicants can suggest areas of expertise to be included on a given panel, though no assurance is given that suggested review domains will be utilized. Please do not recommend reviewers by name to avoid potential conflicts of interest. However, applicants can provide names of potential reviewers whom they would prefer not be used, and every effort will be made to accommodate these requests. These requests should be included in a letter uploaded with the other supporting documents.

Click here to view the review criteria.

List only individuals who are considered key personnel or significant contributors to the work that will be performed, and who have agreed to their role. Avoid honorific collaborations. For all proposals, the review committee requires that investigators collaborate closely with clinicians and product development experts in the development of the proposal and the conduct of the work. The input of these collaborators must be clearly reflected throughout the application.

Please do not submit copies of relevant publications. Standard citation of publications is acceptable.

Videos are not accepted.

It is the official sheet from your research administration office indicating that your full proposal has been approved by your institution’s sponsored research office. Be sure to ask your research administration office how much lead time they need to process this form in the event you are invited to submit a full proposal, so that you can submit all your documents before the deadline. A signature from an authorized business official must be received before the proposal deadline.

Funding can support a full array of resources, including core user fees for services such as biostatistics consults or use of specialized lab facilities. Funds are typically used for student/postdoc support, reagent costs, and small equipment. Capital and non-capital equipment must be well justified to the project's purpose and exclusive needs. Alterations and renovations will not be supported.

Indirect costs are provided a.) at a performance site’s federally negotiated rate and/or b.) to companies at the standard IRS rate of 10%, unless a company can substantiate a different federally negotiated rate.

The timeliness of your revisions to the administrative materials and obtaining any necessary protocol approvals will affect when you receive your award, which will be on or around September 1, 2027. If your work involves human subjects (either data or tissue derived) or live animals, the necessary IRB and IACUC approvals must be received by the Center before the activation of your award.

An annual progress report must be submitted by investigators in accordance with the award's terms and conditions. Brief monthly reports and occasional follow-up meetings are required so that CAPCaT can follow the progress of your projects.

Applicants can submit Expressions of Interest in multiple research areas to the appropriately aligned Center solicitations. Only one submission, if selected, will be allowed to move to the full proposal stage. This will be decided among the Center Leadership for the best fit within the goals of the POCTRN.